课题基金 / 基金详情

DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery

DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery
DRAGON 2 - 一项国际多中心随机对照试验，比较肝脏手术中联合门静脉和肝静脉栓塞术 (PVE/HVE) 与单独 PVE 的效果
批准号：
463216
负责人：
Martel Guillaume
金额：
$46.83万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=463216&lang=en
关键词：
Hepatectomy Hepatic Vein Embolization Interventional Radiology Liver Metastatic Colorectal Cancer Portal Vein Embolization Randomized Controlled Trial Regeneration Resectability Survival

项目摘要

项目成果

Martel Guillaume的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients who suffer from colorectal cancer that has spread to the liver (metastases) can be treated with liver surgery. Liver surgery is the most effective treatment in improving survival for this disease, and up to 30% of patients can be cured. Liver sur
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
  • 批准号：
    463049
  • 项目类别：
    Operating Grants
  • 资助金额：
    $5.29万
  • 财政年份：
    2022
  • 负责人：
    Martel Guillaume
  • 依托单位：
    Ottawa Hospital Research Institute
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
  • 批准号：
    460778
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.09万
  • 财政年份：
    2022
  • 负责人：
    Martel Guillaume
  • 依托单位：
    Ottawa Hospital Research Institute
PRICE 2: A phase 3 randomized controlled trial of phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections
海外基金